Ajay Bansal

Ajay Bansal

Direttore Finanziario/CFO presso UROVANT SCIENCES LTD.
64 anni
Health Technology
Commercial Services
Finance

Profilo

Ajay Bansal currently works at Urovant Sciences Ltd., as Chief Financial Officer & SVP-Business Development from 2019.
Mr. Bansal also formerly worked at Capital One Financial Corp., as Director-Operations Analysis from 2002 to 2003, Nektar Therapeutics, as Chief Financial Officer from 2003 to 2006, Lexicon Pharmaceuticals, Inc., as CFO & Executive VP-Business Development in 2010, Tercica, Inc., as CFO & Executive VP-Business Development from 2007 to 2008, Onconova Therapeutics, Inc., as Chief Financial Officer & Secretary from 2014 to 2016, ViewRay Technologies, Inc., as Chief Financial & Accounting Officer, Complete Genomics, Inc., as Chief Financial Officer from 2012 to 2013, ViewRay, Inc., as Chief Financial & Accounting Officer from 2016 to 2019, McKinsey & Co., Inc., as Engagement Manager from 1988 to 1991, Mehta Partners LLC, as Partner from 1998 to 2002, ZS Associates, Inc., as Consultant from 1985 to 1987, and Novartis Pharmaceuticals Corp., as Principal.
Mr. Bansal received his graduate degree in 1985 and Masters Business Admin degree in 1985 from Northwestern University and undergraduate degree in 1984 from Indian Institute of Technology New Delhi.

Posizioni attive di Ajay Bansal

SocietàPosizioneInizio
UROVANT SCIENCES LTD. Direttore Finanziario/CFO 28/10/2019

Precedenti posizioni note di Ajay Bansal

SocietàPosizioneFine
VIEWRAY SYSTEMS, INC. Direttore Finanziario/CFO 30/09/2019
TRAWS PHARMA, INC. Direttore Finanziario/CFO 12/02/2016
COMPLETE GENOMICS, INC. Direttore Finanziario/CFO 01/03/2013
LEXICON PHARMACEUTICALS, INC. Direttore Finanziario/CFO 08/01/2010
Direttore Finanziario/CFO 01/10/2008
Vedi nel dettaglio l'esperienza di Ajay Bansal

Formazione di Ajay Bansal

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

70

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private15

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Ajay Bansal
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA